Aqui-S®20E is a liquid containing 10% eugenol that is applied as an immersion bath treatment. Aqui-S®20E is only available for purchase through AquaTactics Fish Health / AQATAQ Vaccines. The primary goal of field studies conducted under INAD #11-741 is to evaluate the efficacy of Aqui-S®20E for use as an anesthetic/sedative in all freshwater-reared finfish, freshwater prawn, all saltwater-reared finfish, and sharks. Fish may be treated between 10 – 100 milligram (mg) eugenol per L for up to 15 minutes. Treatment duration will vary dependent upon species, water temperature, and level of sedation desired. AQUI-S® 20E should be applied as a single treatment event. Note: For sedation to handleable, a treatment dosage of 20-60 mg eugenol per L is recommended for all species. For field use, both freshwater and saltwater finfish treated with AQUI-S®20E can be released immediately back into their natural environment; for hatchery use, a 72-hour Investigational withdrawal period is required. To participate in the INAD Program for AQUI-S®20E visit the data collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, MSDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letter(s) for this INAD is currently only available by emailing Bonnie Johnson .
INAD objective/purpose: Collect scientific data necessary to establish the effectiveness AND safety of AQUI-S® 20E as an anesthetic/sedative in a variety of fish species under a variety of environmental conditions.
AquaTactics Fish Health / AQATAQ Vaccines
12015 115th Avenue NE, Suite 120
Kirkland, WA 98034
Target pathogen(s): Not Applicable
Method of administration: Immersion; standing bath treatment only
Investigational Withdrawal period:
Required test parameters:
Limitations or restrictions on use of drug:
Required INAD fee: $700/facility/year
AADAP Contact Information:
Ms. Bonnie Johnson, FWS-AADAP